Company also Applying its High-throughput RNA-amplicon Sequencing Platform to Accelerate COVID-19 Testing Efforts May 20, 2020 08:30 AM Eastern Daylight Time EMERYVILLE, Calif.–(BUSINESS WIRE)–Octant, Inc...
Funding & investments
AbCellera Receives $175.6 million from the Government of Canada to Discover Solutions for COVID-19 and Build a Manufacturing Facility for Antibody Drugs
AbCellera’s world-leading drug discovery technology identifies antibodies for potential use in drugs to treat and prevent COVID-19. ANCOUVER, British Columbia–(BUSINESS WIRE)–AbCellera announced today it has...
